Aclaris Therapeutics, Inc. expanded its senior R&D team and recently appointed Ian Anderson, Ph.D., as Executive Vice President, Translational Research & Development. Dr. Anderson brings more than 30 years of immunology research experience in drug development, from discovery through Phase 2. He previously held senior scientific leadership roles at Flame Biosciences, Janssen Pharmaceutical, MedImmune and Cambridge Antibody Technology.